EP3519049
ÖRUGG OG ÁHRIFARÍK AÐFERÐ TIL AÐ MEÐHÖNDLA SÓRÍASIS MEÐ SÉRTÆKUM MÓTEFNUM GEGN IL23
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
29.9.2017EP published:
3.12.2025EP application number:
17857471.1
EP translation filed:
12.1.2026Grant published:
11.2.2026EPO information:
European Patent Register
Max expiry date:
28.9.2037Expiry date:
28.9.2026
Title in English:
SAFE AND EFFECTIVE METHOD OF TREATING PSORIASIS WITH ANTI-IL23 SPECIFIC ANTIBODYLanguage of the patent:
English
Timeline
Today
29.9.2017EP application
3.12.2025EP Publication
12.1.2026Translation submitted
11.2.2026Registration published
28.9.2026Expires
Owner
Name:
Janssen Biotech, Inc.Address:
800/850 Ridgeview Drive, Horsham, PA 19044, US
Inventor
Name:
RANDAZZO, BruceAddress:
Spring House Pennsylvania 19477, US
Name:
WASFI, YasmineAddress:
Spring House Pennsylvania 19477, US
Agent
Name:
Novagraaf BrevetsAddress:
Bâtiment O2, 2 rue Sarah Bernhardt CS90017, FR
Priority
Number:
201662402403 PDate:
30.9.2016Country:
US
Number:
201762532068 PDate:
13.7.2017Country:
US
Classification
Categories:
C07K 16/24, A61P 25/00, A61P 37/00